Smithkline Beecham Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SMITHKLINE BEECHAM, and what generic and branded alternatives to SMITHKLINE BEECHAM drugs are available?
SMITHKLINE BEECHAM has three approved drugs.
Summary for Smithkline Beecham
US Patents: | 0 |
Tradenames: | 3 |
Ingredients: | 3 |
NDAs: | 3 |
Drug Master File Entries: | 2 |
Patent Litigation for Smithkline Beecham: | See patent lawsuits for Smithkline Beecham |
Drugs and US Patents for Smithkline Beecham
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-001 | Apr 12, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Smithkline Beecham | RELAFEN | nabumetone | TABLET;ORAL | 019583-001 | Dec 24, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-002 | Dec 20, 1990 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-001 | Dec 20, 1990 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-002 | Apr 12, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Smithkline Beecham | RELAFEN | nabumetone | TABLET;ORAL | 019583-002 | Dec 24, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Smithkline Beecham
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Smithkline Beecham | RELAFEN | nabumetone | TABLET;ORAL | 019583-001 | Dec 24, 1991 | 4,420,639*PED | ⤷ Sign Up |
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-002 | Apr 12, 1988 | 4,375,547 | ⤷ Sign Up |
Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-002 | Dec 20, 1990 | 4,466,972 | ⤷ Sign Up |
Smithkline Beecham | RELAFEN | nabumetone | TABLET;ORAL | 019583-002 | Dec 24, 1991 | 4,061,779 | ⤷ Sign Up |
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-001 | Apr 12, 1988 | 4,375,547 | ⤷ Sign Up |
Smithkline Beecham | RELAFEN | nabumetone | TABLET;ORAL | 019583-001 | Dec 24, 1991 | 4,061,779 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SMITHKLINE BEECHAM drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Oral Solution | 15 mg/mL | ➤ Subscribe | 2008-05-14 |
Similar Applicant Names
Here is a list of applicants with similar names.